2026-01-17
4 Core Pharma Intermediates: 6-Bromohexyl Acetate (CAS:8052-41-3), EDC·HCl (CAS:25952-53-8), 2-Aminothiazole-4-acetic Acid (CAS:29676-71-9), (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzyl Alcohol HCl (CAS:521284-22-0)
In the pharmaceutical R&D and production chain, pharmaceutical intermediates, as key "bridge" substances, directly affect the efficiency, purity, and safety of drug synthesis. This article focuses on four cost-effective core pharmaceutical intermediates—6-Bromohexyl Acetate, 1-Ethyl-3-(dimethylaminopropyl)carbodiimide Hydrochloride, 2-Aminothiazole-4-acetic Acid, and (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzyl Alcohol Hydrochloride—providing a detailed analysis of their core characteristics and application value to offer precise product references for pharmaceutical R&D enterprises and chemical production manufacturers.
I. 6-Bromohexyl Acetate (CAS: 8052-41-3): A Versatile Intermediate in Organic Synthesis
As an important halohydrocarbon ester compound, 6-Bromohexyl Acetate is an indispensable organic synthesis intermediate in the pharmaceutical and chemical fields, and also a high-performance raw material for dry cleaning solvents. Its core characteristics and application advantages are as follows:
-
Core Properties: Insoluble in water, soluble in common organic solvents such as ethyl acetate and dichloromethane, with diverse chemical reactivity; bromine atoms and ester groups can achieve efficient chemical transformation;
-
Synthetic Applications: Can be prepared by esterification of 6-bromohexanol and acetic anhydride, widely used in the preparation of 1,6-difunctionalized hexane molecules, compatible with various reaction types such as nucleophilic substitution and Reformatsky, facilitating the construction of complex drug molecular skeletons;
-
SEO Keywords: 6-Bromohexyl Acetate CAS 8052-41-3 Supplier, Pharmaceutical Grade 6-Bromohexyl Acetate, 6-Bromohexyl Acetate for Organic Synthesis
II. 1-Ethyl-3-(dimethylaminopropyl)carbodiimide Hydrochloride (CAS: 25952-53-8): A High-Efficiency Coupling Agent for Amide Bond Formation
Referred to as EDC·HCl for short, it is a core coupling agent in modern synthetic chemistry, especially outstanding in amide bond and ester bond formation reactions in drug synthesis. With excellent performance, it has become one of the preferred reagents in peptide synthesis and bioconjugation fields.
-
Core Advantages: Good water solubility, the urea by-product generated after the reaction is easy to remove, compatible with solution-phase and solid-phase synthesis; when used with activators such as N-hydroxysuccinimide (NHS), it can greatly improve reaction efficiency;
-
Main Applications: Widely used in amino acid coupling to form peptide skeletons and protein-nucleic acid cross-linking, it is a key condensing agent in the synthesis of anti-insomnia drugs such as Suvorexant, enabling efficient condensation reactions under mild conditions and reducing by-product generation;
-
SEO Keywords: EDC·HCl CAS 25952-53-8 Price, Coupling Agent for Peptide Synthesis, Pharmaceutical Grade 1-Ethyl-3-(dimethylaminopropyl)carbodiimide Hydrochloride
III. 2-Aminothiazole-4-acetic Acid (CAS: 29676-71-9): Core Intermediate for Cephalosporin Drug Synthesis
Due to its unique thiazole ring structure, this intermediate has become a key raw material for cephalosporin antibiotic synthesis, especially playing an irreplaceable role in the preparation of clinically commonly used drug Cefotiam, with stable market demand and concentrated application scenarios.
-
Synthetic Characteristics: Can be prepared by condensation of chloro/bromoacetoacetic acid ethyl ester with thiourea followed by hydrolysis; the synthesis process is mature, easy for industrial mass production, and the product purity can reach over 95%;
-
Application Value: Exclusively serves cephalosporin drug manufacturing, is the core unit for constructing the molecular structure of Cefotiam, and can also be used as a basic raw material for thiazole derivative synthesis, expanding to the field of antibacterial drug R&D;
-
SEO Keywords: 2-Aminothiazole-4-acetic Acid CAS 29676-71-9 Cefotiam Intermediate, Cephalosporin Drug Raw Material Supplier, High Purity 2-Aminothiazole-4-acetic Acid
IV. (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzyl Alcohol Hydrochloride (CAS: 521284-22-0): Key Intermediate for Mirabegron Synthesis
As a core intermediate of Mirabegron, a selective β3-adrenergic receptor agonist, this compound directly determines the synthesis efficiency and product quality of Mirabegron. Mirabegron is mainly used to treat symptoms such as urgency and frequent urination caused by overactive bladder, with wide clinical application.
-
Product Characteristics: Appearance is white solid, stable chemical structure, with properties related to selective serotonin reuptake inhibitors, laying the foundation for the pharmacological activity of Mirabegron;
-
Application Scenarios: Exclusively compatible with industrial synthesis of Mirabegron, is a key link in the construction of the drug's molecular skeleton, and can also be used as an important reference raw material for the R&D of anti-urinary system disease drugs;
-
SEO Keywords: Mirabegron Intermediate CAS 521284-22-0 Supplier, (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzyl Alcohol Hydrochloride, Anti-Urinary Incontinence Drug Raw Material
Conclusion: Precise Selection of Intermediates Empowers Cost-Effective Pharmaceutical R&D
The above four pharmaceutical intermediates have undergone strict quality control, with advantages such as high purity, good stability, and compatibility with industrial production. Whether you are a R&D and production enterprise of cephalosporin antibiotics, anti-insomnia drugs, or urinary system disease drugs, selecting suitable core intermediates is the key to improving product competitiveness.
For more product details (such as specifications and parameters, quotations, sample applications), please feel free to contact us. We will provide you with customized product solutions and professional technical support!
